NYC VC Fund Launch: Relentless Closes $80M+ Debut Fund From Index Ventures Alum
New York-based Relentless closed its debut fund at over $80 million in 2026, founded by former Index Ventures partner Damir Becirovic with a concentrated seed strategy.
NYC Venture Capital News & Fund Activity
New York's venture capital scene moves fast — from multi-hundred-million-dollar fund closes to breakout seed rounds in fintech and AI. Our NYC VC news coverage tracks the firms, funds, and deals that matter for founders raising in the city.
NYC VC News Coverage
- Fund launches: Debut funds, successor vehicles, and emerging managers
- Notable rounds: Seed through growth deals across key NYC sectors
- Firm moves: Partner changes, thesis shifts, and portfolio milestones
- Market context: How NYC deal flow compares nationally
Stay current with NYC venture capital news below.
Related Articles (46 articles)
-
-
NYC VC Fund News: Dimension Capital Files for $750M Fund III at ML × Life Sciences Intersection
New York-based Dimension Capital filed SEC Form D in June 2026 seeking up to $750M for its third fund, following $350M Fund I and $500M Fund II.
-
NYC VC Fund News: Eckuity Capital Holds First Close of Healthcare Growth Fund II
New York-based Eckuity Capital announced the first close of Fund II on June 26, 2026, extending its commercial-stage life sciences growth strategy across North America and Europe.
-
NYC Fund Launch: Colbeck Capital Launches $400M Strategic Income Direct Lending Vertical
New York-based Colbeck Capital Management launched Colbeck Strategic Income with $400M on June 24, 2026, expanding its middle-market private credit platform.
-
NYC VC Fund Launch: Gutter Capital Closes $75M Fund III, Expands Elbow Grease Accelerator
New York-based Gutter Capital announced the $75M close of Fund III on June 15, 2026, alongside applications for the second cohort of its NYC Elbow Grease accelerator.
-
NYC VC Fund Launch: Star51 Capital First Close of Medtech Venture Fund
New York-based Star51 Capital announced the first close of its inaugural medtech venture fund on June 11, 2026, anchored by Abbott and Mayo Clinic.
-
NYC VC Fund Launch: Animal Capital Closes $33M Fund III for Consumer Tech
New York-based Animal Capital announced the $33M close of Fund III on June 11, 2026, continuing its early-stage consumer technology investment strategy.
-
NYC VC Fund Launch: Blue Cloud Ventures Closes Fund V, Crosses $1B AUM
New York-based Blue Cloud Ventures announced the final close of Fund V on June 2, 2026, bringing total AUM above $1 billion for enterprise SaaS and AI growth investing.
-
NYC VC Fund Launch: Opto Investments Closes AI-Focused Venture Fund for RIAs
New York-based Opto Investments announced the close of its AI-focused venture fund on May 28, 2026, providing RIA and family office clients exposure to foundational AI infrastructure.
-
July 2025 Growth Equity Close: Glade Brook Raises $515M Fund IV
Greenwich and Miami-based Glade Brook Capital closed Strategic Growth Fund IV at $515 million on July 22, 2025, targeting FinTech, AI, SpaceTech, and DefenseTech growth equity.
-
NYC VC Fund Launch: Betaworks Closes $66M Fund III for Early-Stage AI
New York City-based Betaworks announced the $66M close of Fund III on July 22, 2025, continuing its legacy of backing creative technologists building AI-native products.
-
NYC VC Fund Launch: Quartus Capital Closes $50M+ AI Fund for Growth-Stage Tech
New York-based Quartus Capital Partners closed its Quartus AI Fund LP at $50M+ on July 14, 2025, deploying into growth-stage AI ventures across healthcare, education, and logistics.